Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity

Journal of Immunology

Volumn 179, Issue 5, 2007, Pages 3362-3370

  Ballan, Wassim M ^a,b   Vu, Bien Aimee N ^a   Long, Brian R ^a   Loo, Christopher P ^a   Michaëlsson, Jakob ^c   Barbour, Jason D ^a   Lanier, Lewis L ^a   Wiznia, Andrew A ^d   Abadi, Jacobo ^d   Fennelly, Glenn J ^d   Rosenberg, Michael G ^d   Nixon, Douglas F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR 46; NATURAL KILLER CELL RECEPTOR NKG2C; PROTEIN P46; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR; KIR2DL3 PROTEIN, HUMAN; NATURAL KILLER CELL ACTIVATING RECEPTORS; NCR1 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL STIMULATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MALE; NATURAL KILLER CELL; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; COMPARATIVE STUDY; DEGRANULATION; FLOW CYTOMETRY; HOSPITALIZATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INFANT; LYMPHOCYTE COUNT;

ADOLESCENT; CELL DEGRANULATION; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; INFANT; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MALE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, KIR2DL3; SEVERITY OF ILLNESS INDEX;

EID: 38449121925     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.5.3362     Document Type: Article

References (73)

1. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47: 187-376.
2. Hamerman, J. A., K. Ogasawara, and L. L. Lanier. 2005. NK cells in innate immunity. Curr. Opin. Immunol. 17: 29-35.
3. Zingoni, A., T. Sornasse, B. G. Cocks, Y. Tanaka, A. Santoni, and L. L. Lanier. 2005. NK cell regulation of T cell-mediated responses. Mol. Immunol. 42: 451-454.
4. Martin, M. P., X. Gao, J. H. Lee, G. W. Nelson, R. Detels, J. J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, J. Trowsdale, et al. 2002. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31: 429-434.
5. Karre, K., H. G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319: 675-678.
6. Vilches, C., and P. Parham. 2002. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu. Rev. Immunol. 20: 217-251.
7. Wada, H., N. Matsumoto, K. Maenaka, K. Suzuki, and K. Yamamoto. 2004. The inhibitory NK cell receptor CD94/NKG2A and the activating receptor CD94/ NKG2C bind the top of HLA-E through mostly shared but partly distinct sets of HLA-E residues. Eur. J. Immunol. 34: 81-90.
8. Bauer, S., V. Groh, J. Wu, A. Steinle, J. H. Phillips, L. L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727-729.
9. Chalupny, N. J., C. L. Sutherland, W. A. Lawrence, A. Rein-Weston, and D. Cosman. 2003. ULBP4 is a novel ligand for human NKG2D. Biochem. Biophys. Res. Commun. 305: 129-135.
10. Cosman, D., J. Mullberg, C. L. Sutherland, W. Chin, R. Armitage, W. Fanslow, M. Kubin, and N. J. Chalupny. 2001. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14: 123-133.
11. Aldemir, H., V. Prod'homme, M. J. Dumaurier, C. Retiere, G. Poupon, J. Cazareth, F. Bihl, and V. M. Braud. 2005. Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor. J. Immunol. 175: 7791-7795.
12. Rosen, D. B., J. Bettadapura, M. Alsharifi, P. A. Mathew, H. S. Warren, and L. L. Lanier. 2005. Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor. J. Immunol. 175: 7796-7799.
13. Sivori, S., D. Pende, C. Bottino, E. Marcenaro, A. Pessino, R. Biassoni, L. Moretta, and A. Moretta. 1999. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells: correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur. J. Immunol. 29: 1656-1666.
14. Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M. C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19: 197-223.
15. Biassoni, R., C. Cantoni, D. Pende, S. Sivori, S. Parolini, M. Vitale, C. Bottino, and A. Moretta. 2001. Human natural killer cell receptors and co-receptors. Immunol. Rev. 181: 203-214.
16. + T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand. Proc. Natl. Acad. Sci. USA 102: 10981-10986.
17. Erkeller-Yuksel, F. M., V. Deneys, B. Yuksel, I. Hannet, F. Hulstaert, C. Hamilton, H. Mackinnon, L. T. Stokes, V. Munhyeshuli, F. Vanlangendonck, et al. 1992. Age-related changes in human blood lymphocyte subpopulations. J. Pediatr. 120: 216-222.
18. McDonald, T., J. Sneed, W. R. Valenski, M. Dockter, R. Cooke, and H. G. Herrod. 1992. Natural killer cell activity in very low birth weight infants. Pediatr. Res. 31: 376-380.
19. Dominguez, E., J. A. Madrigal, Z. Layrisse, and S. B. Cohen. 1998. Fetal natural killer cell function is suppressed. Immunology 94: 109-114.
20. Yabuhara, A., H. Kawai, and A. Komiyama. 1990. Development of natural killer cytotoxicity during childhood: marked increases in number of natural killer cells with adequate cytotoxic abilities during infancy to early childhood. Pediatr. Res. 28: 316-322.
21. Gasparoni, A., L. Ciardelli, A. Avanzini, A. M. Castellazzi, R. Carini, G. Rondini, and G. Chirico. 2003. Age-related changes in intracellular TH1/TH2 cytokine production, immunoproliferative T lymphocyte response and natural killer cell activity in newborns, children and adults. Biol. Neonate 84: 297-303.
22. - cell populations in cord blood and adult peripheral blood. J. Immunol. 135: 2351-2356.
23. Kohl, S., J. J. Frazier, S. B. Greenberg, L. K. Pickering, and L. S. Loo. 1981. Interferon induction of natural killer cytotoxicity in human neonates. J. Pediatr. 98: 379-384.
24. Kohl, S., M. S. West, and L. S. Loo. 1988. Defects in interleukin-2 stimulation of neonatal natural killer cytotoxicity to herpes simplex virus-infected cells. J. Pediatr. 112: 976-981.
25. Wilson, C. B. 1986. Immunologic basis for increased susceptibility of the neonate to infection. J. Pediatr. 108: 1-12.
26. + and NK lymphocytes in the direct cell-to-cell interaction. Clin. Immunol. 112: 258-267.
27. Bradstock, K. F., C. Luxford, and P. G. Grimsley. 1993. Functional and phenotypic assessment of neonatal human leucocytes expressing natural killer cell-associated antigens. Immunol. Cell. Biol. 71: 535-542.
28. Rabian-Herzog, C., S. Lesage, and E. Gluckman. 1992. Characterization of lymphocyte subpopulations in cord blood. Bone Marrow Transplant. 9(Suppl. 1): 64-67.
29. + T cells. Blood 101: 2711-2720.
30. + granular lymphocytes with a natural killer-sensitive tumor cell, K562. J. Exp. Med. 161: 1464-1482.
31. Valentin, A., M. Rosati, D. J. Patenaude, A. Hatzakis, L. G. Kostrikis, M. Lazanas, K. M. Wyvill, R. Yarchoan, and G. N. Pavlakis. 2002. Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 99: 7015-7020.
32. De Maria, A., M. Fogli, P. Costa, G. Murdaca, F. Puppo, D. Mavilio, A. Moretta, and L. Moretta. 2003. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur. J. Immunol. 33: 2410-2418.
33. Qi, Y., M. P. Martin, X. Gao, L. Jacobson, J. J. Goedert, S. Buchbinder, G. D. Kirk, S. J. O'Brien, J. Trowsdale, and M. Carrington. 2006. KIR/HLA pleiotropism: protection against both HIV and opportunistic infections. PLoS Pathog. 2: E79.
34. Barbour, J. D., U. Sriram, S. J. Caillier, J. A. Levy, F. M. Hecht, and J. R. Oksenberg. 2007. Synergy or independence? Deciphering the interaction of HLA class I and NK cell KIR alleles in early HIV-1 disease progression. PLoS Pathog. 3: E43.
35. Gaudieri, S., D. DeSantis, E. McKinnon, C. Moore, D. Nolan, C. S. Witt, S. A. Mallal, and F. T. Christiansen. 2005. Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression. Genes Immun. 6: 683-690.
36. Carr, W. H., D. B. Rosen, H. Arase, D. F. Nixon, J. Michaelsson, and L. L. Lanier. 2007. Cutting edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. J. Immunol. 178: 647-651.
37. Jennes, W., S. Verheyden, C. Demanet, C. A. Adje-Toure, B. Vuylsteke, J. N. Nkengasong, and L. Kestens. 2006. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J. Immunol. 177: 6588-6592.
38. Azzoni, L., E. Papasavvas, J. Chehimi, J. R. Kostman, K. Mounzer, J. Ondercin, B. Perussia, and L. J. Montaner. 2002. Sustained impairment of IFN-γ secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immunity. J. Immunol. 168: 5764-5770.
39. Brenner, B. G., C. Gryllis, M. Gornitsky, and M. A. Wainberg. 1993. Changes in natural immunity during the course of HIV-1 infection. Clin. Exp. Immunol. 93: 142-148.
40. Cai, Q., X. L. Huang, G. Rappocciolo, and C. R. Rinaldo, Jr. 1990. Natural killer cell responses in homosexual men with early HIV infection. J. Acquired Immune Defic. Syndr. 3: 669-676.
41. Mavilio, D., J. Benjamin, M. Daucher, G. Lombardo, S. Kottilil, M. A. Planta, E. Marcenaro, C. Bottino, L. Moretta, A. Moretta, and A. S. Fauci. 2003. Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc. Natl. Acad. Sci. USA 100: 15011-15016.
42. Ullum, H., P. C. Gotzsche, J. Victor, E. Dickmeiss, P. Skinhoj, and B. K. Pedersen. 1995. Defective natural immunity: an early manifestation of human immunodeficiency virus infection. J. Exp. Med. 182: 789-799.
43. Ahmad, A., and J. Menezes. 1996. Antibody-dependent cellular cytotoxicity in HIV infections. FASEB J. 10: 258-266.
44. + cells and expansion of a population of CD16dimCD56- cells with low lytic activity. J. Acquired Immune. Defic. Syndr. Hum. Retrovirol. 10: 331-340.
45. Ljunggren, K., A. Karlson, E. M. Fenyo, and M. Jondal. 1989. Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection. Clin. Exp. Immunol. 75: 184-189.
46. Alter, G., J. M. Malenfant, R. M. Delabre, N. C. Burgett, X. G. Yu, M. Lichterfeld, J. Zaunders, and M. Altfeld. 2004. Increased natural killer cell activity in viremic HIV-1 infection. J. Immunol. 173: 5305-5311.
47. Mavilio, D., G. Lombardo, A. Kinter, M. Fogli, A. La Sala, S. Ortolano, A. Farschi, D. Follmann, R. Gregg, C. Kovacs, et al. 2006. Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. J. Exp. Med. 203: 2339-2350.
48. Jenkins, M., J. Mills, and S. Kohl. 1993. Natural killer cytotoxicity and antibody-dependent cellular cytotoxicity of human immunodeficiency virus-infected cells by leukocytes from human neonates and adults. Pediatr. Res. 33: 469-474.
49. Luzuriaga, K., D. Holmes, A. Hereema, J. Wong, D. L. Panicali, and J. L. Sullivan. 1995. HIV-1-specific cytotoxic T lymphocyte responses in the first year of life. J. Immunol. 154: 433-443.
50. Bernstein, H. B., A. L. Kinter, R. Jackson, and A. S. Fauci. 2004. Neonatal natural killer cells produce chemokines and suppress HIV replication in vitro. AIDS Res. Hum. Retroviruses 20: 1189-1195.
51. + cell counts in treated HIV-1-infected children. J. Infect. Dis. 191: 1451-1459.
52. Alter, G., J. M. Malenfant, and M. Altfeld. 2004. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 294: 15-22.
53. Betts, M. R., and R. A. Koup. 2004. Detection of T-cell degranulation: CD107a and b. Methods Cell. Biol. 75: 497-512.
54. Baumgarth, N., and M. Roederer. 2000. A practical approach to multicolor flow cytometry for immunophenotyping. J. Immunol. Methods 243: 77-97.
55. Perfetto, S. P., P. K. Chattopadhyay, and M. Roederer. 2004. Seventeen-colour flow cytometry: unravelling the immune system. Nat. Rev. Immunol. 4: 648-655.
56. Roederer, M. 2001. Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. Cytometry 45: 194-205.
57. Bancroft, G. J. 1993. The role of natural killer cells in innate resistance to infection. Curr. Opin. Immunol. 5: 503-510.
58. Cerwenka, A., and L. L. Lanier. 2001. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1: 41-49.
59. French, A. R., and W. M. Yokoyama. 2003. Natural killer cells and viral infections. Curr. Opin. Immunol. 15: 45-51.
60. Fontana, L., M. C. Sirianni, G. de Sanctis, M. Carbonari, B. Ensoli, and F. Aiuti. 1986. Deficiency of natural killer activity, but not of natural killer binding, in patients with lymphoadenopathy syndrome positive for antibodies to HTLV-III. Immunobiology 171: 425-435.
61. Goodier, M. R., N. Imami, G. Moyle, B. Gazzard, and F. Gotch. 2003. Loss of the CD56hiCD16- NK cell subset and NK cell interferon-γ production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone. Clin. Exp. Immunol. 134: 470-476.
62. Kottilil, S., T. W. Chun, S. Moir, S. Liu, M. McLaughlin, C. W. Hallahan, F. Maldarelli, L. Corey, and A. S. Fauci. 2003. Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function. J. Infect. Dis. 187: 1038-1045.
63. Parato, K. G., A. Kumar, A. D. Badley, J. L. Sanchez-Dardon, K. A. Chambers, C. D. Young, W. T. Lim, S. Kravcik, D. W. Cameron, and J. B. Angel. 2002. Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10. AIDS 16: 1251-1256.
64. Dunn, D. 2003. Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis. Lancet 362: 1605-1611.
65. Mela, C. M., C. T. Burton, N. Imami, M. Nelson, A. Steel, B. G. Gazzard, F. M. Gotch, and M. R. Goodier. 2005. Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy. AIDS 19: 1761-1769.
66. Guma, M., C. Cabrera, I. Erkizia, M. Bofill, B. Clotet, L. Ruiz, and M. Lopez-Botet. 2006. Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J. Infect. Dis. 194: 38-41.
67. Bonaparte, M. I., and E. Barker. 2004. Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules. Blood 104: 2087-2094.
68. Bonaparte, M. I., and E. Barker. 2003. Inability of natural killer cells to destroy autologous HIV-infected T lymphocytes. AIDS 17: 487-494.
69. Alter, G., T. J. Suscovich, M. Kleyman, N. Teigen, H. Streeck, M. T. Zaman, A. Meier, and M. Altfeld. 2006. Low perforin and elevated SHIP-1 expression is associated with functional anergy of natural killer cells in chronic HIV-1 infection. AIDS 20: 1549-1551.
70. Qi, W., J. Yongjun, W. Yanan, Z. Zining, H. Xiaoxu, L. Jing, and S. Hong. 2006. Differential expression of perforin in cytotoxic lymphocyte in HIV/AIDS patients of China. J. Clin. Immunol. 26: 339-346.
71. + T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 281: 65-78.
72. Alter, G., N. Teigen, B. T. Davis, M. M. Addo, T. J. Suscovich, M. T. Waring, H. Streeck, M. N. Johnston, K. D. Staller, M. T. Zaman, et al. 2005. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 106: 3366-3369.
73. + natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc. Natl. Acad. Sci. USA 102: 2886-2891.